Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects

Summary

A double-blind, placebo-controlled, phase I study to assess safety, tolerability and pharmacokinetics of single/multiple ascending doses of atb-346 orally administered in healthy male and female subjects.

Timeline

Start

2014-06

Primary completion

2014-12

Completion

2014-12

Drugs

Indications